Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-009133
Filing Date
2018-04-02
Accepted
2018-04-02 20:22:32
Documents
1
Period of Report
2018-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4304
  Complete submission text file 0000899243-18-009133.txt   5869
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
BEIER DAVID W (Reporting) CIK: 0001187054 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31141 | Film No.: 18731024